Skip to main content
. 2023 Oct 6;41(36):5550–5560. doi: 10.1200/JCO.23.00882

FIG 1.

FIG 1.

Kaplan-Meier plots for (A) PFS and (B) OS by breast cancer clinical subtype. HER2+, human epidermal growth factor receptor 2–positive; HER2–, HER2-negative; HR+, hormone receptor–positive; OS, overall survival; PFS, progression-free survival; TNBC, triple-negative breast cancer.